MHRA-100754-PIP01-22

Key Facts

Active Substance
Active Substance:
  • Live-attenuated La Reunion strain of chikungunya virus
Invented Name
Not yet available
PIP Number MHRA-100754-PIP01-22
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Powder and solvent for suspension for injection
Therapeutic area
Therapeutic area:
  • Vaccines
Conditions / Indications
Conditions / Indications:
  • Prevention of chikungunya virus disease
Route(s) of administration
Route(s) of administration:
  • intramuscular
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Live-attenuated La Reunion strain of chikungunya virus .pdf
Published Date 19/12/2023